India Exchange Filings

Q3 2026 Earnings and Board Meeting Highlights

Sanofi India Ltd reports Q3 2026 net profit of ₹116.7 crore and declares ₹75 interim dividend

  • Revenue was ₹491.7 crore, up 3.4% year on year and 12.3% sequentially.
  • PBT before exceptional items rose 21.7% year on year; Q3 2025 included a ₹27.3 crore personnel-separation charge.
  • Interim dividend record date: 5 November 2026; limited review found no matters indicating material misstatement.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.